​

Avalo Therapeutics Ownership | Who Owns Avalo Therapeutics?

OverviewForecastRevenueFinancialsChart

Avalo Therapeutics Ownership Summary

Avalo Therapeutics is owned by 136.98% institutional investors, 3.82% insiders. Bvf inc/il is the largest institutional shareholder, holding 12.51% of AVTX shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.05% of its assets in Avalo Therapeutics shares.

AVTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAvalo Therapeutics136.98%3.82%-40.80%
SectorHealthcare Stocks 41.87%10.80%47.33%
IndustryBiotech Stocks 43.97%10.75%45.28%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bvf inc/il1.36M12.51%$17.23M
Orbimed advisors1.35M12.46%$17.15M
Nantahala capital management1.24M11.40%$15.70M
Point72 asset management1.05M9.73%$13.40M
Affinity asset advisors1.01M9.29%$12.79M
Caligan partners lp833.33K7.69%$10.59M
Silverarc capital management720.92K6.66%$9.16M
Vanguard group692.64K6.40%$8.80M
Ra capital management662.97K6.12%$8.43M
Tcg crossover management483.00K4.46%$6.14M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp263.64K3.15%$3.35M
Superstring capital management lp188.08K2.36%$2.39M
Caligan partners lp833.33K1.39%$10.59M
Ally bridge group (ny)178.10K1.38%$2.26M
Silverarc capital management720.92K1.24%$9.16M
Affinity asset advisors1.01M1.11%$12.79M
Exome asset management100.04K0.77%$1.27M
Bvf inc/il1.36M0.70%$17.23M
Allostery investments lp9.00K0.57%$44.91K
Nantahala capital management1.24M0.55%$15.70M

Top Buyers

HolderShares% AssetsChange
Point72 asset management1.05M0.02%1.05M
Caligan partners lp833.33K1.39%833.33K
Silverarc capital management720.92K1.24%720.92K
Vanguard group692.64K0.00%525.70K
Affinity asset advisors1.01M1.11%398.35K

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp144.60K0.05%-422.50K
Ra capital management662.97K0.10%-270.00K
Adviser investments86.52K0.01%-174.50K
Allostery investments lp9.00K0.57%-98.14K
Adar1 capital management32.39K0.04%-72.34K

New Positions

HolderShares% AssetsChangeValue
Point72 asset management1.05M0.02%1.05M$13.40M
Caligan partners lp833.33K1.39%833.33K$10.59M
Silverarc capital management720.92K1.24%720.92K$9.16M
Adage capital partners gp258.77K0.01%258.77K$3.29M
Ameriprise financial213.57K0.00%213.57K$2.71B

Sold Out

HolderChange
Raymond james financial-1.00
Hrt financial lp-10.29K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20256997.14%14,834,68589.14%1362.61%47261.54%8-33.33%
Jun 30, 2025356.06%7,843,040-4.99%721.18%13-13.33%12200.00%
Mar 31, 202533-8,255,0579.62%781.52%15-11.76%433.33%
Dec 31, 20243317.86%7,530,52113.12%711.07%1730.77%3200.00%
Sep 30, 20242833.33%6,656,933763.30%8191.00%1318.18%1-75.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr113.90K1.05%-51.90K
abrdn Life Sciences Investors72.80K0.55%72.80K
Fidelity Extended Market Index52.95K0.40%-224.00
Extended Equity Market Fund K19.15K0.18%-382.00
iShares Micro-Cap ETF21.12K0.16%-
Fidelity Total Market Index18.59K0.14%-40.00
NT Ext Equity Mkt Idx Fd - NL11.56K0.11%-
Fidelity Series Total Market Index13.40K0.10%-
Spartan Extended Market Index Pool F13.10K0.10%435.00
NT Ext Equity Mkt Idx Fd - L10.61K0.10%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 14, 2025Goldman Jonathan-Sell$45.29K
Nov 14, 2025Goldman Jonathan-Sell$117.65K
Nov 12, 2024Almenoff June Sherie-Buy$6.25K
Nov 13, 2024Almenoff June Sherie-Buy$6.50K
Jun 26, 2023ARMISTICE CAPITAL, LLC-Sell$1.68M

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q42-

AVTX Ownership FAQ

Who Owns Avalo Therapeutics?

Avalo Therapeutics shareholders are primarily institutional investors at 136.98%, followed by 3.82% insiders and -40.80% retail investors. The average institutional ownership in Avalo Therapeutics's industry, Biotech Stocks , is 43.97%, which Avalo Therapeutics exceeds.

Who owns the most shares of Avalo Therapeutics?

Avalo Therapeutics’s largest shareholders are Bvf inc/il (1.36M shares, 12.51%), Orbimed advisors (1.35M shares, 12.46%), and Nantahala capital management (1.24M shares, 11.40%). Together, they hold 36.38% of Avalo Therapeutics’s total shares outstanding.

Does Blackrock own Avalo Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Avalo Therapeutics.

Who is Avalo Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Avalo Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.15% of its assets in 263.64K Avalo Therapeutics shares, valued at 3.35M$.

Who is the top mutual fund holder of Avalo Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Avalo Therapeutics shares, with 1.05% of its total shares outstanding invested in 113.9K Avalo Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools